From: TCP1 regulates PI3K/AKT/mTOR signaling pathway to promote proliferation of ovarian cancer cells
Characteristics | N | IOD/area | P |
---|---|---|---|
Age (years) | 0.271 | ||
< 60 | 47 | 0.074 ± 0.043 | |
≥ 60 | 15 | 0.087 ± 0.037 | |
Tumour size | 0.72 | ||
< 5 cm | 14 | 0.074 ± 0.037 | |
≥ 5 cm | 48 | 0.078 ± 0.043 | |
FIGO Stage (2009) | 0.001* | ||
I + II | 30 | 0.060 ± 0.033 | |
III + IV | 32 | 0.094 ± 0.043 | |
Histological subtype | 0.052 | ||
Serous | 38 | 0.086 ± 0.044 | |
Mucinous | 17 | 0.065 ± 0.026 | |
Clear cell | 4 | 0.014 ± 0.007 | |
Endometrioid | 3 | 0.091 ± 0.069 | |
Grade of differentiationa | 0.001* | ||
Low | 27 | 0.050 ± 0.023 | |
High | 35 | 0.091 ± 0.042 | |
Lymph node metastasisb | 0.137 | ||
Positive | 9 | 0.100 ± 0.048 | |
Negative | 47 | 0.073 ± 0.040 | |
The volume of ascites | 0.27 | ||
Positive | 29 | 0.083 ± 0.039 | |
Negative | 33 | 0.072 ± 0.044 |